An analysis of Illumina's stock performance reveals substantial returns for a $1,000 investment made 20 years ago. The article highlights the long-term growth trajectory of the genomics company.
Illumina Investment Over Two Decades Shows Significant Growth
ILMNStock PerformanceInvestment ReturnsBiotechnology



